English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Feb 6, 2026

Eli Lilly expands tirzepatide trials into immunology with combination therapies
+ Pharmaceuticals
Patient Daily | Feb 6, 2026

AbbVie stresses growth beyond immunology as Skyrizi and Rinvoq lead 2025 sales
+ Pharmaceuticals
Patient Daily | Feb 6, 2026

Rare disease drug development sees growth amid regulatory changes
+ Pharmaceuticals
Patient Daily | Feb 6, 2026

Novo Nordisk focuses on Wegovy pill launch amid rising competition and declining sales outlook
+ Pharmaceuticals
Patient Daily | Feb 6, 2026

Penn Medicine workshop uses writing as therapy for cancer patients
+ Pharmaceuticals
Patient Daily | Feb 6, 2026

One quarter of youth on mental health drugs take risky combinations
+ Pharmaceuticals
Patient Daily | Feb 6, 2026

Research highlights importance of promoting thriving for high-quality aged care
+ Pharmaceuticals
Patient Daily | Feb 6, 2026

Study finds autism diagnosis rates nearly equal between males and females by adulthood

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes